Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 1.00 |
| ▸ | NPC1 | O15118 | 3/20 | 1.00 |
| ▸ | RAB9A | P51151 | 3/20 | 1.00 |
| ▸ | POLB | P06746 | 2/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | PDE4A | P27815 | 2/20 | 1.00 |
| ▸ | PDE4B | Q07343 | 2/20 | 1.00 |
| ▸ | PDE4C | Q08493 | 2/20 | 1.00 |
| ▸ | PDE4D | Q08499 | 2/20 | 1.00 |
| ▸ | PADI1 | Q9ULC6 | 2/20 | 1.00 |
| ▸ | PADI3 | Q9ULW8 | 2/20 | 1.00 |
| ▸ | PADI4 | Q9UM07 | 2/20 | 1.00 |
| ▸ | PADI2 | Q9Y2J8 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | TGM2 | P21980 | 1/20 | 1.00 |
| ▸ | GALK1 | P51570 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Streptonigrin SCHEMBL29821157 | 1.00 | MAPT (1.00) | MAPTLMNASMN1; SMN2NPC1RAB9A | |
| Streptonigrin SCHEMBL29371276 | 1.00 | MAPT (1.00) | MAPTLMNASMN1; SMN2NPC1RAB9A | |
| Streptonigrin SCHEMBL29374011 | 1.00 | MAPT (1.00) | MAPTLMNASMN1; SMN2NPC1RAB9A | |
| SCHEMBL25015126 | 0.93 | MAPT (0.87) | MAPTLMNASMN1; SMN2NPC1RAB9A | |
| SCHEMBL30260509 | 0.93 | MAPT (0.87) | MAPTLMNASMN1; SMN2NPC1RAB9A | |
| Streptonigrin SCHEMBL23421492 | 0.92 | LMNA (0.85) | MAPTLMNASMN1; SMN2NPC1RAB9A | |
| Streptonigrin SCHEMBL6299739 | 0.91 | LMNA (0.84) | MAPTLMNASMN1; SMN2NPC1RAB9A | |
| SCHEMBL23484220 | 0.89 | FNTA (0.82) | MAPTLMNASMN1; SMN2NPC1RAB9A | |
| SCHEMBL20257205 | 0.85 | SMN1; SMN2 (0.75) | MAPTLMNASMN1; SMN2NPC1RAB9A | |
| SCHEMBL29885591 | 0.82 | LMNA (0.70) | MAPTLMNASMN1; SMN2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 43745 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4748859-A2 | CHEMICALLY AND PHOTOCHEMICALLY INITIATED CELL MEMBRANE BLEBBING TO INDUCE CELL VESICLE PRODUCTION, MODIFICATIONS THEREOF, AND USES THEREOF | The Regents of the University of California (US) | 2026-05-27 | — | — | EP | claimed |
| US-20260115305-A1 | LINKERS, CONJUGATES AND APPLICATIONS THEREOF | GENEQUANTUM HEALTHCARE SUZHOU CO LTD (CN) | 2026-04-30 | — | — | US | claimed |
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| US-20260085100-A1 | METHODS OF ANTIGEN PRODUCTION | THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY (US) | 2026-03-26 | — | — | US | claimed |
| US-20260077056-A1 | LINKER-PAYLOAD COMPOUND, CONJUGATES AND APPLICATIONS THEREOF | GENEQUANTUM HEALTHCARE SUZHOU CO LTD (CN) | 2026-03-19 | — | — | US | claimed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | claimed |
| EP-4698185-A1 | METHODS AND SYSTEMS FOR IMPROVING ANTI-CANCER THERAPIES | Osasuna Therapeutics SA (CH) | 2026-02-25 | — | — | EP | claimed |
| EP-4694935-A1 | COMBINATION OF ANTIBODY-DRUG CONJUGATE AND ANTI-PD-1 ANTIBODY, AND USE THEREOF | Genequantum Healthcare (Suzhou) Co., Ltd. (CN) | 2026-02-18 | — | — | EP | claimed |
| EP-4694909-A1 | METHODS OF MODULATING THE EPITHELIAL-MESENCHYMAL TRANSITION | RS Oncology, LLC (US) | 2026-02-18 | — | — | EP | claimed |
| EP-0563507-B1 | Transdermal patch incorporating a polymer film incorporated with an active agent | BERTEK INC (US) | 1998-05-27 | — | — | EP | claimed |
| US-5681737-A | USING SALMONELLA STRAINS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1997-10-28 | — | — | US | claimed |
| US-5679373-A | MELT-BLENDING THERMOPLASTIC MATRIX; IMPERMEABLE BACKING; LAMINATION WITHOUT ADHESIVE; CONTROLLED RELEASE | BERTEK, INC. (US) | 1997-10-21 | — | — | US | claimed |
| WO-1997033611-A1 | METHOD OF KILLING TARGET CELLS IN HARVESTED CELL POPULATIONS WITH ONE OR MORE IMMUNOTOXINS | FODSTAD OEYSTEIN (NO) | 1997-09-18 | — | — | WO | claimed |
| US-5662926-A | SOLVENT FREE | BERTEK, INC. (US) | 1997-09-02 | — | — | US | claimed |
| EP-0723597-A1 | A DETECTION SYSTEM FOR MUTAGENS THAT ALSO IDENTIFIES MUTAGENIC CHANGES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1996-07-31 | — | — | EP | claimed |
| EP-0652231-A1 | NON-TOXIC RIBOSOME INACTIVATING PROTEINS (RIPs) WITH TWO CHAINS, PROCESS FOR THE PREPARATION THEREOF AND APPLICATIONS | UNIVERSIDAD DE VALLADOLID (ES) | 1995-05-10 | — | — | EP | claimed |
| WO-1995010629-A1 | A DETECTION SYSTEM FOR MUTAGENS THAT ALSO IDENTIFIES MUTAGENIC CHANGES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1995-04-20 | — | — | WO | claimed |
| EP-0563507-A1 | Transdermal patch incorporating a polymer film incorporated with an active agent | MLI ACQUISITION CORP. II (US) | 1993-10-06 | — | — | EP | claimed |
| EP-0227593-A1 | Use of chelating agents | THE HOSPITAL FOR SICK CHILDREN (CA) | 1987-07-01 | — | — | EP | claimed |